HighPoint Advisor Group’s Endocare, Inc. NEW Common Stock ENDO Stock Holding History

HighPoint Advisor Group’s Portfolio ENDO Stock Details ENDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,000	Closed	-$1	–	703
2024 Q4	$1	Hold	12,000	–	–	﹤0.01%	696
2024 Q3	$1	Hold	12,000	–	–	﹤0.01%	698
2024 Q2	$0	Hold	12,000	–	–	﹤0.01%	648
2024 Q1	$0	Hold	12,000	–	–	﹤0.01%	673
2023 Q4	$0	Buy	+12,000	New	–	﹤0.01%	653
2022 Q2	$0	Buy	+12,000	New	–	﹤0.01%	538
2021 Q3	$0	Hold	12,000	–	–	﹤0.01%	607
2021 Q2	$0	Hold	12,000	–	–	﹤0.01%	581
2021 Q1	$0	Hold	12,000	–	–	﹤0.01%	544
2020 Q4	$0	Buy	+12,000	New	–	﹤0.01%	516

HighPoint Advisor Group's ENDO Position: Q1 2025 in Review

HighPoint Advisor Group sold out of Endocare, Inc. NEW Common Stock (ENDO) in Q1 2025, closing a stake of 12,000 shares — an estimated $1 sold.

HighPoint Advisor Group first reported a position in ENDO in Q4 2020 and held it in 10 quarters. The position peaked at $1 in Q4 2024. 0 funds tracked by Wall St. Rank hold ENDO as of Q1 2025.

HighPoint Advisor Group reported no remaining Endocare, Inc. NEW Common Stock position as of Q1 2025 after selling out during the quarter.
HighPoint Advisor Group sold 12,000 Endocare, Inc. NEW Common Stock shares in Q1 2025, an estimated $1.
HighPoint Advisor Group first reported a position in Endocare, Inc. NEW Common Stock in Q4 2020 and held it in 10 quarters.
HighPoint Advisor Group's Endocare, Inc. NEW Common Stock position peaked at $1 in Q4 2024.
0 funds tracked by Wall St. Rank held Endocare, Inc. NEW Common Stock as of Q1 2025.

Based on HighPoint Advisor Group's 13F filing for Q1 2025, filed 5 May 2025.